|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net Income/(Loss) | |||||
| Adjustments to reconcile net income/(loss) to cash provided by operating activities: | |||||
| Depreciation of property, plant and equipment and amortization of customer relationships and other intangible assets | |||||
| Amortization of capitalized contract costs | |||||
| Accretion of asset retirement obligations | |||||
| Provision for credit losses | |||||
| Amortization of nuclear fuel | |||||
| Amortization of financing costs and debt discounts | |||||
| Loss/(gain) on debt extinguishment | |||||
| Amortization of in-the-money contracts and emissions allowances | |||||
| Amortization of unearned equity compensation | |||||
| Net loss/(gain) on sale of assets and disposal of assets | |||||
| Gain on proceeds from insurance recoveries for property, plant and equipment, net | |||||
| Impairment losses | |||||
| Changes in derivative instruments | |||||
| Changes in current and deferred income taxes and liability for uncertain tax benefits | |||||
| Changes in collateral deposits in support of risk management activities | |||||
| Changes in nuclear decommissioning trust liability | |||||
| Uplift securitization proceeds received from ERCOT | |||||
| Equity in and distributions from earnings of unconsolidated affiliates | |||||
| Cash (used)/provided by changes in other working capital: | |||||
| Accounts receivable - trade | |||||
| Inventory | |||||
| Prepayments and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Other assets and liabilities | |||||
| Cash provided/(used) by operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Payments for acquisitions of businesses and assets, net of cash acquired | |||||
| Capital expenditures | |||||
| Proceeds from sales of assets, net of cash disposed | |||||
| Net purchases of emissions allowances | |||||
| Proceeds from insurance recoveries for property, plant and equipment, net | |||||
| Investments in nuclear decommissioning trust fund securities | |||||
| Proceeds from the sale of nuclear decommissioning trust fund securities | |||||
| Cash used by investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Proceeds from issuance of preferred stock, net of fees | |||||
| Equivalent shares purchased in lieu of tax withholdings | |||||
| Payments for share repurchase activity and excise tax | |||||
| Payment for settlement of capped call options | |||||
| Payments of dividends to preferred and common stockholders | |||||
| Proceeds from issuance of long-term debt | |||||
| Repayments of long-term debt and finance leases | |||||
| Payments for debt extinguishment costs | |||||
| Payments of deferred financing costs | |||||
| Proceeds from issuance of common stock | |||||
| Net receipts/(payments) from settlement of acquired derivatives that include financing elements | |||||
| Proceeds from credit facilities | |||||
| Repayments to credit facilities | |||||
| Cash provided/(used) by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net Increase/(Decrease) in Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash | |||||
| Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash at Beginning of Period | |||||
| Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash at End of Period | |||||
Loading...